Assertio Holdings, Inc. (ASRT)
23.44
+0.07
(+0.30%)
USD |
NASDAQ |
May 22, 16:00
23.44
0.00 (0.00%)
Pre-Market: 20:00
Assertio Holdings EPS Diluted (Quarterly) : -2.931 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Merck & Co., Inc. | -1.715 |
| Lipocine, Inc. | -0.5404 |
| Theravance Biopharma, Inc. | -0.0962 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.86M |
| Revenue (Quarterly) | 9.933M |
| Total Expenses (Quarterly) | 28.79M |
| Enterprise Value | 119.15M |
| Gross Profit Margin (Quarterly) | 13.91% |
| Profit Margin (Quarterly) | -189.8% |
| Earnings Yield | -24.46% |
| Normalized Earnings Yield | -22.57 |